Many studies have suggested that increased baseline neurogranin levels are indicative of future cognitive deterioration in patients with MCI20,41,42, while a few studies have suggested that low baseline neurogranin levels are indicative of future cognitive deterioration22. This evidence concerns the gene NRGN and cognition.